The Effect of zinc supplementation versus placebo on the improvement of clinical symptoms among students with premenstrual syndrome

Phase 2

• Conditions: Premenstrual syndrome.; N94.3; Premenstrual tension syndrome

• Registration Number: IRCT20120215009014N347
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 March 2020

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 86

Inclusion Criteria

Age of 18 to 35 years,
Premenstrual syndrome,
Student resident of dormitory of Hamadan University of Medical Sciences,

Exclusion Criteria

Malnutrition,
Sepsis,
Acute meningitis,
Unstable hemodynamic status,
Diarrhea,
Mood or psychological disorder

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of clinical symptoms of premenstrual symptoms. Timepoint: Before the intervention and then after first, second, third, and sixth months after the intervention. Method of measurement: Using Premenstrual Symptoms Screening Tool (PSST) questionnaire.

Secondary Outcome Measures

Name	Time	Method
The severity of pain. Timepoint: Before the intervention and then after first, second, third, and sixth months after the intervention. Method of measurement: Using Visual analog Scale (VAS).;The severity of hemorrhage. Timepoint: Before the intervention and then after first, second, third, and sixth months after the intervention. Method of measurement: By taking history.;The duration of hemorrhage. Timepoint: Before the intervention and then after first, second, third, and sixth months after the intervention. Method of measurement: By taking history.